CHF30.60
0.16% day before yesterday
SIX Swiss Exchange, Jul 04, 05:30 pm CET
ISIN
CH0038389992
Symbol
BION

BB Biotech Stock price

CHF30.60
-0.10 0.33% 1M
-5.70 15.70% 6M
-4.80 13.56% YTD
-9.15 23.02% 1Y
-26.40 46.32% 3Y
-39.55 56.38% 5Y
-25.40 45.36% 10Y
-38.90 55.97% 20Y
SIX Swiss Exchange, Closing price Fri, Jul 04 2025
+0.05 0.16%
ISIN
CH0038389992
Symbol
BION
Sector

Key metrics

Basic
Market capitalization
CHF1.6b
Enterprise Value
CHF-286.8m
Net debt
positive
Cash
CHF1.9b
Shares outstanding
54.7m
Valuation (TTM | estimate)
P/E
negative | 7.7
P/S
23.7 | 12.0
EV/Sales
negative | negative
EV/FCF
negative
P/B
0.9
Dividends
DPS
CHF1.80
Yield 1Y | 5Y
5.9% | 4.8%
Growth 1Y | 5Y
-10.0% | -11.9%
Payout 1Y | 3Y
130.4% | -74.8%
Increased
0 Years
Financials (TTM | estimate)
Revenue
CHF69.2m | CHF136.9m
EBITDA
- | CHF172.1m
EBIT
CHF35.6m | CHF172.1m
Net Income
CHF-425.5m | CHF217.7m
Free Cash Flow
CHF522.5m
Growth (TTM | estimate)
Revenue
-74.5% | 22.0%
EBITDA
- | -
EBIT
-84.6%
Net Income
-238.3% | 186.9%
Free Cash Flow
504.4%
Margin (TTM | estimate)
Gross
94.8%
EBITDA
- | 125.7%
EBIT
51.4%
Net
-615.2% | 159.0%
Free Cash Flow
755.4%
Financial Health
Equity Ratio
95.0%
Return on Equity
3.3%
ROCE
1.8%
ROIC
237.4%
Debt/Equity
0.0
More
EPS
CHF-7.8
FCF per Share
CHF9.6
Short interest
-
Employees
10
Rev per Employee
CHF11.2m
Show more

Is BB Biotech a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,966 stocks worldwide.

BB Biotech Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a BB Biotech forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a BB Biotech forecast:

Buy
90%
Hold
10%

Financial data from BB Biotech

Assets
Mar '25
1,949 1,949
Cash 1,929 1,929
Claims 19 19
Inventories - -
Other current assets Other current assets Current assets 0.06 0.06
- -
Property, plant and equipment - -
Financial assets - -
Intangible Assets - -
Other fixed assets Other assets Fixed assets - -
Total Assets 1,949 1,949
Liabilities
Mar '25
Equity 1,944 1,944
4.42 4.42
Current liabilities 4.42 4.42
Non-current liabilities - -
Total Capital 1,949 1,949

In millions CHF.

Don't miss a Thing! We will send you all news about BB Biotech directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BB Biotech Stock News

AD HOC NEWS
26 days ago
Edison issues report on BB Biotech (BION)
AD HOC NEWS
2 months ago
BB BIOTECH AG / CH0038389992
AD HOC NEWS
2 months ago
BB BIOTECH AG / CH0038389992
More BB Biotech News

Company Profile

BB Biotech AG is a closed-end investment fund, which engages in investing in biotechnology companies. It focuses on the development and commercialization of novel drugs sectors. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.

Head office Switzerland
Employees 10
Founded 1993
Website www.bbbiotech.ch

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today